{"search_session":{},"preferences":{"l":"fr","queryLanguage":"fr"},"patentId":"124-286-716-704-728","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"124-286-716-704-728","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":10753,"type":"PATENT","title":"Paris-Sud University: Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":2442,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8235,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately:\"univ* paris sud\"; \"univ* paris 11\"; \"univ* paris xi\"; \"Paris-Sud Univ*\".
Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 2075
Search Applicants and Owners separately:\"univ* paris sud\"; \"univ* paris 11\"; \"univ* paris xi\"; \"Paris-Sud Univ*\".
Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 2075
a) At least one therapeutic agent for use according to any one of claims 1-6; and/or
b) At least one expression vector according to claim 7; and/or
c) At least one host cell according to claim 8; and/or
d) A pharmaceutical composition according to any one of claims 9 to 11."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["A screening method for a therapeutic agent for use in the treatment of disease associated with cellular metabolism reprogramming comprising the steps of:
a) Providing SNAT7 protein;
b) Contacting said SNAT7 protein with a therapeutic agent candidate;
c) Determining the effect of said therapeutic agent candidate on the SNAT7 protein glutamine transport activity;
d) Selecting said therapeutic agent candidate if it significantly reduces or inhibits SNAT7 protein glutamine transport activity as determined in step c)."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["A screening method for a therapeutic agent according to claim 13, wherein said disease associated with cellular metabolism reprogramming is a cancer-associated with cellular metabolism reprogramming, preferentially is a cancer depending on glutamine."],"number":14,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}